Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

about

Four-Year Evolution of a Thrombophylaxis Protocol in an Enhanced Recovery After Surgery (ERAS) Program: Recent Results in 485 Patients.

P2860

Q55532665-8A6B1450-122D-414E-8425-591A4EB98602

P2860

Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

Item

http://www.wikidata.org/entity/Q38888249

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

@en

type

Item

label

Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

@en

prefLabel

Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

@en

P1476

Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

@en

P2093

Bramnik Zakhar

http://www.w3.org/2001/XMLSchema#string

Farraj Moaad

http://www.w3.org/2001/XMLSchema#string

Farraj Safy

http://www.w3.org/2001/XMLSchema#string

Kvasha Anton

http://www.w3.org/2001/XMLSchema#string

Merie Moner

http://www.w3.org/2001/XMLSchema#string

Sbeit Wisam

http://www.w3.org/2001/XMLSchema#string

Waksman Igor

http://www.w3.org/2001/XMLSchema#string

P2860

Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients

Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta)

Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery.

Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature.

Role of fibrinolysis in obesity and thrombosis.

Platelet dysfunction in central obesity.

A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery.

Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery.

Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass.

Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.

P2888

s11695-017-2638-1

P31

scholarly article

P356

10.1007/S11695-017-2638-1

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28326488

http://www.w3.org/2001/XMLSchema#string

P921

bariatric surgery

anticoagulation

Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

about

P2860

P2860

Is LMWH Sufficient for Anticoagulant Prophylaxis in Bariatric Surgery? Prospective Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P698

P921